Business
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope.
About this update from Zomedica Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope \r\n \r\n \r\n\r\n\r\nZomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope \r\n\r\n\r\n\r\n\r\n\r\nIntellectual Property Portfolio grows to 221 Patents and 140 Trademarks ANN ARBOR, MI / ACCESS Newswire / June 24, 2025 / Zomedica Corp. (OTCQB:ZOMDF) (\"Zomedica\" or the \"Company\"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the issuance of a new patent related to its TRUVIEW microscope and provided an update on the Company's current intellectual property portfolio.\r\n The U.S. Patent related to the TRUVIEW microscope, manufactured, sold and distributed by Zomedica, was U.S. Patent No. 12,299,917 B2 issued recently for the Methods and Systems for Slide Imaging Calibration.\r\n Bill Campbell, Zomedica's Vice President of Imaging Systems and inventor of the TRUVIEW microscope, stated, \"Securing this patent is a significant milestone that underscores our commitment to innovation in digital microscopy. This protection not only validates the uniqueness of our focusing system but also strengthens our position as a leader in imaging solutions. We are excited about the possibilities this opens for enhancing image quality and usability in clinical applications.\r\n With the addition of this recently issued patent, Zomedica's IP portfolio now includes 77 issued U.S. patents and 144 issued international patents as well as 33 registered U.S. trademarks and 107 registered foreign trademarks related to its therapeutic device and diagnostic products.\r\n Larry Heaton, Chief Executive Officer of Zomedica stated, \"We are pleased to add this patent protecting our innovative TRUVIEW device to our growing portfolio. The Zomedica Research & Development team has been actively expanding our intellectual property portfolio through ongoing development of our innovative products. This protection enables us to devote resources to investing in growing new markets for our unique products, knowing that Zomedica's highly differentiated proprietary products will remain unique.\"\r\n About Zomedica\r\n Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innov...